Efficacy and safety of a generic remifentanil formulation versus fentanyl and Ultiva during general anaesthesia: A phase III, prospective, multi-centric, observer-blind, randomised controlled trial.
Our study's findings demonstrated that generic remifentanil is non-inferior to fentanyl and equivalent to Ultiva for general anaesthesia in Indian patients undergoing various surgical and diagnostic procedures. Remifentanil offers advantages in terms of optimum haemodynamic stability, fast equilibrating analgesia, and rapid emergence from sedation, making it a suitable alternative to fentanyl.
Authors
- C. L. Gurudatt
- Ashok Kumar Swain (ORCID: https://orcid.org/0000-0001-9874-9869)
- Indrani Hemantkumar (ORCID: https://orcid.org/0000-0002-4976-6547)
- Manjaree Mishra (ORCID: https://orcid.org/0000-0002-8915-3956)
- Swati Singh (ORCID: https://orcid.org/0000-0003-2482-7902)
- Janampet Bekkam Giridhar
Institutions
- Institute of Medical Sciences (IN)
- JSS Medical College and Hospital (IN)
- Banaras Hindu University (IN)
Publication Details
- Journal
- PubMed
- Published
- 2024-11-01
- DOI
- https://doi.org/10.4103/ija.ija_289_24
- Citations
- 2
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 1.28